Clearside Biomedical, Inc.'s Chief Financial Officer just picked up 10,000 shares

Charles A. Deignan, Clearside Biomedical, Inc.'s Chief Financial Officer, recently acquired 10,000 shares of the company. The buys took place at $1.36 per share, on March 15, 2019. Deignan now owns 76,356 shares of the company. Deignan operates out of Alpharetta, GA. Some additional info was provided as follows:

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Clearside Biomedical, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Clearside Biomedical Provides New Drug Application Update For Xipere - Aug. 22, 2019
Clearside Biomedical, Inc.'s CEO just picked up 100,000 shares - Aug. 8, 2019
Clearside Biomedical, Inc. Just Filed Its Quarterly Report: 12. Net Loss Per Sha... - Aug. 8, 2019
Clearside Biomedical Announces Second Quarter 2019 - Aug. 7, 2019

Auto Refresh